Growth Portfolio: ALS Limited (ALQ) - Buy
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Overview: ALS Ltd ("ALQ", "the Company") is an Australian commercial services company focused on testing and quality assurance. The Company undertakes food and pharmaceutical quality assurance; mining and mineral exploration; commodity certification; equipment maintenance, and asset care operations. It operates one of the world’s largest analytical and testing services businesses in more than 50 countries with over 300 locations. The Company was founded in 1863 and listed on the ASX in 1952. The Company was previously known as Campbell Brothers. It is a member of the ASX100 index.
Catalysts: Following last year’s divestment of its oil and gas services unit, ALQ’s financial position has been strengthening. Earnings are rebounding strongly whilst the Company has used surplus capital to undertake share buybacks and acquisitions in the less cyclical life sciences industries. Aiming to increase EBITDA by more than 70% by 2022, further earnings growth is the primary driver for ALQ.
Hurdles: Over a third of the Company’s revenue is driven by commodity industries where demand is subject to cyclical trends and has impacted financial performance in the past. The Company relies to a significant degree on acquisitions to drive growth and must restore confidence in its ability to deliver value-accretive deals following an unsuccessful foray into oil and gas during 2013 (since divested).
Investment View: ALQ offers profitable exposure to the mineral sampling and food testing industries. We are attracted to its strong market position, reputation, high barriers to entry, and growth targets. As its financial performance rebounds solidly from recent cyclical lows, the Company aims to increase EBITDA by over 70% by 2022. Further commodities industry cyclical weakness and integration risks associated with recent acquisitions are the principal risks. Whilst the stock trades at a premium valuation to the market, its high entry barriers, share buyback program, and growth trajectory, create a favourable balance of risks and we rate the stock a ‘buy’.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.